NVCR News and Press, NovoCure Limited From 08/12/19

SHANGHAI, China and ST. HELIER, Jersey, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB), a Shanghai-based innovative commercial stage biopharmaceutical company, and Novocure (NASDAQ: NVCR), a global oncology company with a proprietary platform technology called Tumor Treati...

This stock idea is totally out of range for TheMoneyMadam except for one metric and that is call option potential; that potential allows you to generate income on a non-dividend stock. If you believe in your pick, you can concentrate on reaping gains from a growth stock while you work the call...

Novocure (NASDAQ: NVCR) announced today that it will participate in three upcoming investor conferences. Pritesh Shah, Novocure’s Chief Commercial Officer, will participate in the Wedbush PacGrow Healthcare Conference on August 14, 2019, in New York City. Mr. Shah’s present...

This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. Winning Bounc...

NovoCure ( NVCR ) reported strong Q2 results, beating both revenue and EPS estimates. Part of the beat was a non-recurring $5 million revenue benefit, but Optune has delivered strong sequential and Y/Y growth even if the one-time benefit is excluded. NovoCure saw good news on all fronts in...

KalVista Pharmaceuticals (NASDAQ: KALV ) initiated with Outperform rating and $31 (83% upside) price target at SVB Leerink. More news on: KalVista Pharmaceuticals, Inc., Gilead Sciences, Inc., Galapagos NV, Healthcare stocks news, Stocks on the move, , Read more ...

CRISPR Therapeutics ( CRSP +0.8% ) initiated with Buy rating and $72 price target at Canaccord Genuity. More news on: CRISPR Therapeutics AG, Cue Biopharma, Inc., DENTSPLY SIRONA Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Novocure Limited (NVCR) Q2 2019 Earnings Conference Call July 25, 2019 8:00 AM ET Company Participants Ashley Cordova – Senior Vice President-Finance and Investor Relations Bill Doyle – Executive Chairman Asaf Danziger – Chief Executive Officer Ely Benaim &...

The following slide deck was published by NovoCure Limited in conjunction with their 2019 Q2 earnings Read more ...

NovoCure ( NVCR ) Q2 results : Revenues: $86.7M (+41.0%). More news on: NovoCure Limited, Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...